Retatrutide Dosage: The Complete Guide

Retatrutide hit 24.2% average body weight loss at 48 weeks in Phase 2 trials — more than any other GLP-1-class medication ever tested. The dosage protocol is what separates results from regret.

Retatrutide's dosing schedule looks simple on paper — 2mg, 4mg, 8mg, 12mg. What the tables don't tell you is why the timing matters, what to actually do when side effects show up, and the key decision point most guides completely skip: whether 8mg is enough or you should push to 12mg. That's what this guide is for.

Why Retatrutide Dosing Is Different from Other GLP-1s

Every GLP-1 medication requires titration. Semaglutide does it. Tirzepatide does it. But retatrutide's triple-receptor action makes the ramp-up phase more critical than with either of those compounds.

Here's the thing: when you activate glucagon receptors alongside GLP-1 and GIP, you're doing something metabolically unusual. Glucagon normally raises blood sugar and drives energy expenditure — it's a counter-regulatory hormone. Retatrutide essentially balances that effect with GLP-1's insulin-sensitizing action. Getting the dose wrong early means your body doesn't have time to recalibrate.

That's not a scare tactic. It's just the pharmacological reality that explains why people who rush titration tend to feel awful, and people who follow the 4-week schedule tend to report smoother experiences.

The Half-Life That Makes Once-Weekly Dosing Work

Retatrutide's half-life is approximately 6 days. Steady state — the point where your blood levels stop fluctuating meaningfully between doses — takes about 4–5 weeks at any given dose. This is important because:

1. You can't fully assess tolerability until week 3–4 at each dose. Side effects in week 1 often aren't predictive of week 3 side effects at the same dose.
2. The 4-week escalation window isn't arbitrary. It's calibrated to let your pharmacokinetics stabilize before you layer on more.

If you've ever wondered why some people on retatrutide forums feel fine in week 1 then awful in week 3 — that's steady state building up. It's not the dose becoming "too much." It's the compound reaching full blood levels.

Starting Dose of Retatrutide: The 2mg Week

The TRIUMPH Phase 2 trial used 2mg as the starting dose, and that's become the clinical standard. Some protocols use 1mg for people who are highly sensitive to GLP-1 medications — especially if you've had rough experiences with nausea on semaglutide — but 2mg is where most people begin.

What to Expect at 2mg

Honestly, not much — which is exactly the point. At 2mg you might notice:

• Mild appetite reduction by days 2–3
• Possible light nausea, usually 4–8 hours post-injection
• Some early satiety — feeling full faster than you used to

You probably won't lose meaningful weight here. Some people lose 1–3 lbs in the first 4 weeks; some lose nothing. That's normal. The 2mg phase is about giving your GI tract a heads-up before the actual therapeutic doses hit.

Inject on the same day each week. Pick a day that won't conflict with plans — some people feel off for 24 hours after injection, especially in the early weeks.

Full Week-by-Week Retatrutide Dosing Schedule

Source: TRIUMPH Phase 2 clinical trial (NEJM, 2023). Individual protocols may vary.

For a printable version of this chart, see our Retatrutide Dosage Chart.

How to Handle Dose Escalation if Side Effects Hit

This is where most guides get vague. Here's a concrete framework:

At 4mg, GI symptoms are persistent (3+ days)? Hold at 4mg for an extra 2–4 weeks before going to 8mg. There's no race. The compound will work on whatever timeline your body needs.

Vomiting at any dose? Drop back to the previous dose. Stay there for at least 4 weeks before attempting another increase.

Nausea that's annoying but manageable? That's usually okay to push through. The first week at a new dose is often the roughest; by week 2–3 at the same dose, most people report significant improvement.

The 4mg Phase: Your First Real Data Point

Week 5. You're moving to 4mg. This is when retatrutide starts actually doing something.

The shift at 4mg is usually the most dramatic. People who barely felt anything at 2mg suddenly notice they're full after half a plate. That's the GLP-1 receptor activity kicking in at a meaningful threshold. Combined with GIP activation improving insulin sensitivity, a lot of users report noticeably less cravings for sugar specifically — which is a GIP-mediated effect that doesn't show up as strongly with semaglutide.

Side effects spike briefly for most people when moving from 2mg to 4mg. Nausea is the most common. It usually peaks 4–12 hours after injection and settles over 24–48 hours. Eating a small, low-fat meal before injecting can help — fatty foods delay gastric emptying and make nausea worse when GLP-1 is already slowing things down.

8mg vs 12mg: The Decision Nobody Talks About Properly

Quick tangent that actually matters: Most dosing guides treat 12mg like the obvious destination — just the next rung on the ladder after 8mg. That framing is doing people a disservice.

The TRIUMPH Phase 2 data showed that the 8mg group lost 17.3% of body weight at 48 weeks vs 24.2% for the 12mg group. That's a real difference. But it's also not a mandate to go to 12mg.

Here's the honest framing: 8mg is a fully therapeutic dose. If you're losing weight consistently, tolerating the compound well, and your satiety is where you want it — staying at 8mg indefinitely is a rational, deliberate choice. Not a failure to escalate.

The case for going to 12mg:

• You've plateaued at 8mg for 6+ weeks with meaningful weight still to lose
• You're tolerating 8mg without significant side effects
• You want to maximize the glucagon receptor activation for energy expenditure
• You're in the range that Phase 3 trials have studied most intensively

The case for staying at 8mg:

• Side effects are manageable but present at 8mg (12mg will probably make them worse)
• You're already satisfied with the rate of weight loss
• You've reached or are near your target weight

Neither choice is a clinical failure. 12mg isn't the "real" dose. It's one option.

What TRIUMPH Phase 2 Actually Showed by Dose

Source: Jastreboff et al., NEJM 2023 — TRIUMPH Phase 2 trial.

Vial Size Calculations: What to Actually Draw Up

This is the practical stuff nobody explains clearly enough. Retatrutide vials are typically sold as 5mg, 10mg, or 15mg. Your draw volume depends entirely on how you reconstituted the vial.

How to Calculate Your Draw Volume

Formula: Dose (mg) ÷ Concentration (mg/mL) = Volume to draw (mL)

Example: You have a 10mg vial reconstituted with 2mL bacteriostatic water → Concentration = 5mg/mL

Units listed assume U-100 insulin syringe. A 10mg/mL concentration means 120 units = 1.2mL = 12mg.

For a step-by-step on reconstitution and injection technique, see: How to Inject Retatrutide.

Missed Dose Protocol

You forgot. It happens. Here's exactly what to do:

If You're Less Than 4 Days Late

Inject as soon as you remember. Then return to your regular weekly schedule from that new injection date. If your original day was Monday and you remember Thursday, inject Thursday. Next dose: the following Thursday.

If You're 4–7 Days Late (Close to Next Dose)

Skip the missed dose entirely. Take your next scheduled dose on your regular day. Don't double up — doubling a retatrutide dose would effectively give you 2–3 weeks of compound in a single injection given the half-life dynamics.

If You've Missed More Than 1 Week

This one's trickier. Your blood levels have dropped meaningfully (remember: ~6-day half-life means 50% reduction every 6 days). Resuming at your current dose should generally be fine if you missed only 1–2 weeks. If you've been off for 3+ weeks, some people find it worth dropping back a dose for a week to re-establish tolerability — especially at 12mg. There's no trial data on this specifically, so I'm drawing from community experience and the pharmacokinetics.

Managing Side Effects Without Abandoning the Protocol

The most common retatrutide side effects during titration are GI-related: nausea, vomiting, diarrhea, constipation. They follow a predictable pattern: worst in the first 1–2 weeks at a new dose, then usually fading.

See our full guide on Retatrutide Side Effects for detailed management strategies.

Quick Reference: Side Effect Response

Maintenance Phase: How You Know You're There

Maintenance doesn't get its own section in most guides. Which is weird, because it's actually the majority of time you'll spend on retatrutide.

Maintenance starts when weight loss has slowed to 0–1 lb/week at your target dose and you've reached a weight you're satisfied with, or close to it. At that point, continuing to escalate doesn't make clinical sense. Some people even step the dose down at maintenance — from 12mg to 8mg, or 8mg to 4mg — as their appetite naturally regulates.

Signs you've found your maintenance dose:

• Appetite suppression is consistent but not uncomfortable
• Weight is stable week-to-week
• Side effects, if any, are predictable and manageable
• You're not thinking about food constantly (or obsessively avoiding it)

There's no hard rule on how long maintenance lasts. TRIUMPH Phase 2 ran 48 weeks. Phase 3 data suggests the weight loss effects persist throughout the trial period with continued dosing. What happens when people stop is a separate and important question — weight regain is real with GLP-1 class medications, and retatrutide probably follows the same pattern.

Retatrutide Dosing Protocol Summary

If you want a clean reference for your actual protocol:

Where to Source Retatrutide

Retatrutide is not yet FDA-approved. Clinical trials are ongoing, with Phase 3 results emerging in early 2026. If you're looking for a vetted source for peptide protocols, our recommended vendor is Ascension Peptides — third-party tested, reliable concentration accuracy, and actual lab COAs on request.

For more on using retatrutide effectively, see our Retatrutide Dosage Chart for a printable protocol reference.